Rhythm or rate control in atrial fibrillation--Pharmacological Intervention in Atrial Fibrillation (PIAF): a randomised trial.
By S. Hohnloser, K. Kuck, J. Lilienthal. The Lancet, 2000
1,178 citations recorded by the source corpus.
Subfields: Cardiology and Cardiovascular Medicine
View Paper: https://www.semanticscholar.org/paper/dcd18afed9df3326025dbb8b54637ffe10b5601f
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Cardiology and Cardiovascular Medicine
- Stanley Nattel
- Ulrich Schotten
- A. Goette
- Paulus Kirchhof
- M. Ezekowitz
- Rick A. Nishimura
- Joseph S. Alpert
- Gerhard Hindricks
Citations in the corpus
- ACC/AHA/ESC Guidelines for the Management of Patients With Atrial Fibrillation: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines and Policy Conference (2001, background): “Atrial Fibrillation Investigators (194)† Age greater than or equal to 65 years”
- A comparison of rate control and rhythm control in patients with recurrent persistent atrial fibrillation. (2002, background): “Withagen (8); Bosch Medicentrum Hospital, Den Bosch — H.”
- Atrial fibrillation management: a prospective survey in ESC member countries: the Euro Heart Survey on Atrial Fibrillation. (2005, background): “Diagnostics TTE 757 (78) 1275 (84) 1025 (88) 1332 (87) Chest X-ray 803 (82) 1155 (77) 923 (80) 1321 (86) Holter monitoring 135 (14) 549 (36) 323 (28) 511 (31) Exercise test 126 (13) 442 (29) 234 (20) 263 (17) TEE 114 (12) 173 (11) 227 (20) 166 (11) Electrophysiology 14 (1) 143 (10) 81 (7) 66 (4) Eve”
- Pathophysiological mechanisms of atrial fibrillation: a translational appraisal. (2011, background): “prognosis in AF patients (3, 244), underscoring the need”
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation-executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Committ (2006, positive): “Information about the effects of antiarrhythmic and chronotropic therapies on quality of life is inconsistent (116,130,131).”
- ACC/AHA/ESC 2006 guidelines for the management of patients with atrial fibrillation--executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology Committee for Practice Guidelines (Writing Commit (2006, positive): “Information about the effects of antiarrhythmic and chronotropic therapies on quality of life is inconsistent.(116,130,131) Neither the AFFIRM,(132) RACE,(124) PIAF (Pharmacologic Intervention in Atrial Fibrillation),(125) nor STAF (Strategies of Treatment of Atrial Fibrillation)(126) studies found ”